9 research outputs found
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
Conditionally replicative adenoviruses (CRAds) represent a novel treatment strategy for malignant glioma. Recent studies suggest that the cytopathic effect elicited by these vectors is mediated through autophagy, a form of programmed cell death. Likewise, temozolomide (TMZ), a chemotherapeutic agent used for the treatment of malignant gliomas, also triggers autophagic cell death. In this study, we examined the potential to combine the two treatments in the setting of experimental glioma. In vitro, pretreatment with TMZ followed by CRAd-Surivin-pk7 enhanced cytotoxicity against a panel of glioma cell lines. Western blot analysis showed increased expression of BAX and p53, decreased expression of BCL2 and elevated level of APG5. Treatment with TMZ followed by CRAd-Survivin-pk7 (CRAd-S-pk7) led to a significant over-expression of autophagy markers, acidic vesicular organelles and light-chain 3 (LC3). These results were further evaluated in vivo, in which 90% of the mice with intracranial tumours were long-term survivors (>100 days) after treatment with TMZ and CRAd-S-pk7 (P<0.01). Analysis of tumours ex vivo showed expression of both LC3 and cleaved Caspase-3, proving that both autophagy and apoptosis are responsible for cell death in vivo. These results suggest that combination of chemovirotherapy offers a powerful tool against malignant glioma and should be further explored in the clinical setting
Using enhanced number and brightness to measure protein oligomerization dynamics in live cells
Protein dimerization and oligomerization are essential to most cellular functions, yet measurement of the size of these oligomers in live cells, especially when their size changes over time and space, remains a challenge. A commonly used approach for studying protein aggregates in cells is number and brightness (N&B), a fluorescence microscopy method that is capable of measuring the apparent average number of molecules and their oligomerization (brightness) in each pixel from a series of fluorescence microscopy images. We have recently expanded this approach in order to allow resampling of the raw data to resolve the statistical weighting of coexisting species within each pixel. This feature makes enhanced N&B (eN&B) optimal for capturing the temporal aspects of protein oligomerization when a distribution of oligomers shifts toward a larger central size over time. In this protocol, we demonstrate the application of eN&B by quantifying receptor clustering dynamics using electron-multiplying charge-coupled device (EMCCD)-based total internal reflection microscopy (TIRF) imaging. TIRF provides a superior signal-to-noise ratio, but we also provide guidelines for implementing eN&B in confocal microscopes. For each time point, eN&B requires the acquisition of 200 frames, and it takes a few seconds up to 2 min to complete a single time point. We provide an eN&B (and standard N&B) MATLAB software package amenable to any standard confocal or TIRF microscope. The software requires a high-RAM computer (64 Gb) to run and includes a photobleaching detrending algorithm, which allows extension of the live imaging for more than an hour
2016 Jun 15
In recent years it has been shown that the therapeutic benefits of human mesenchymal stem/
stromal cells (hMSCs) in the Central Nervous System (CNS) are mainly attributed to their secretome.
The implementation of computer-controlled suspension bioreactors has shown to be a viable
route for the expansion of these cells to large numbers. As hMSCs actively respond to their culture
environment, there is the hypothesis that one can modulate its secretome through their use. Herein,
we present data indicating that the use of computer-controlled suspension bioreactors enhanced the
neuroregulatory profile of hMSCs secretome. Indeed, higher levels of
in vitro
neuronal differentiation
and NOTCH1 expression in human neural progenitor cells (hNPCs) were observed when these cells
were incubated with the secretome of dynamically cultured hMSCs. A similar trend was also observed
in the hippocampal dentate gyrus (DG) of rat brains where, upon injection, an enhanced neuronal and
astrocytic survival and differentiation, was observed. Proteomic analysis also revealed that the dynamic
culturing of hMSCs increased the secretion of several neuroregulatory molecules and miRNAs present
in hMSCs secretome. In summary, the appropriate use of dynamic culture conditions can represent
an important asset for the development of future neuro-regenerative strategies involving the use of
hMSCs secretome.We acknowledge the financial support of the Portuguese Foundation for Science and Technology (FCT) for a Ciencia 2007 program and IF Development Grant (AJS), a pre-doctoral fellowship to FGT (SFRH/69637/2010) and a PhD fellowship to SA (SFRH/BD/81495/2011), a Canada Research Chair in Biomedical Engineering (LAB) and a SSE Postdoctoral Fellowship (KMP). Premios Santa Casa Neurociencias - Prize Melo e Castro for Spinal Cord Injury Research. PEst-C/SAU/LA0001/2013-2014. Co-funded by "COMPETE Programa Operacional Factores de Competitividade", QREN, the European Union (FEDER - Fundo Europeu de Desenvolvimento Regional) and by The National Mass Spectrometry Network (RNEM) under the contract REDE/1506/REM/2005.info:eu-repo/semantics/publishedVersio